Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/11/2025

Management of Elevated Triglycerides

Treatment Approach

  • The American College of Cardiology recommends fibrates as the first-line treatment for severe hypertriglyceridemia (≥500 mg/dL), with gemfibrozil being the preferred agent for triglyceride levels ≥1000 mg/dL to prevent pancreatitis 1, 2
  • For severe hypertriglyceridemia (≥1000 mg/dL), gemfibrozil 600 mg twice daily is the first-line treatment due to its well-established efficacy and safety profile 2
  • Fenofibrate is an alternative option (54-160 mg daily) for severe hypertriglyceridemia (≥1000 mg/dL) 3, 4
  • The primary goal of treatment for severe hypertriglyceridemia is to prevent pancreatitis 4
  • A very low-fat diet (10-15% of calories) should be implemented concurrently with fibrate therapy for severe hypertriglyceridemia 4

Lifestyle Modifications and Special Considerations

  • The American College of Cardiology recommends lifestyle modifications, including weight reduction if overweight or obese, decreased intake of simple carbohydrates, reduced alcohol consumption, and increased physical activity, as essential components of treatment for hypertriglyceridemia 1, 3, 6
  • For patients with diabetes, optimizing glycemic control is critical before reassessing triglyceride levels 4
  • In HIV-infected patients receiving antiretroviral therapy, fibrates (gemfibrozil 600 mg twice daily or micronized fenofibrate 54-160 mg daily) are recommended for triglyceride levels >500 mg/dL 3

Mechanism and Efficacy of Treatment

  • Fibrates reduce triglycerides by up to 50%, making them the most potent triglyceride-lowering agents 5
  • Omega-3 fatty acids reduce triglycerides by up to 40% 5
  • Niacin reduces triglycerides by up to 30% 5

Safety Concerns

  • The European Heart Journal recommends avoiding the combination of gemfibrozil with statins due to increased risk of myopathy 6
  • If combination therapy with statins is necessary, fenofibrate is preferred over gemfibrozil 6